German chemical and pharma major Bayer today expressed confidence that it would secure fair trade regulator, the Competition Commission of India’s, nod by April or May for the US$66 billion acquisition of US-based biotech major Monsanto.
India is one of the 30 countries whose approval is needed for the merger to go through. As many as 14 countries have already approved the merger.
The company has secured one approval in the US, while one more is pending. The European Union’s clearance is also awaited.
“We are working with the regulator. We are confident of getting the CCI approval,” said Richard van der Merwe, the senior Bayer representative of South Asia.
Full Content: The Economic Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Hong Kong Authorities Crack Down on Bid-Rigging: 20 Arrested in Corruption Sweep
Apr 18, 2024 by
CPI
EU’s Vestager Cautions Against Telecoms Merger Threats to Competition
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition – Year of the Dragon
Apr 16, 2024 by
CPI
Review Logic and Rules for Concentrations of Undertakings that Do Not Meet the Standard of Notification
Apr 16, 2024 by
CPI
China’s Review of Semiconductor Transactions
Apr 16, 2024 by
CPI
Key Challenges and Tips for Merger Control Filing in China for Listed Companies
Apr 16, 2024 by
CPI
Key Point Review: China SPC Antitrust Judgments in 2023
Apr 16, 2024 by
CPI